Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;26(5):345-51.
doi: 10.1007/BF02897291.

Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase

Affiliations

Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase

G Nocentini et al. Cancer Chemother Pharmacol. 1990.

Abstract

The cytotoxicity of hydroxyurea in combination with 2.2'-bipyridyl-6-carbothioamide (a potential inhibitor of ribonucleotide reductase) on P388 murine leukemia is reported. Synergistic activity was studied using various interpretations of the isobologram method and the combination index method. We evaluated the pros and cons of these methods and their overall usefulness. In our opinion, to obtain all possible information from a compound association, it is important to choose a formally correct method that (a) can quantitatively evaluate synergism or antagonism, (b) may offer the possibility of averaging final results, (c) needs a minimal amount of experimental data, and (d) is rapid. Moreover, we emphasize both the utility of testing at least three molar ratios of compound association and the importance of carefully choosing the fractional inhibition used in calculating the combination effect. Such evaluation of drug combinations gives information essential to the preparation of new anticancer drug regimens and to the early assessment of biochemical interactions.

PubMed Disclaimer

References

    1. Prog Drug Res. 1987;31:101-26 - PubMed
    1. Cancer. 1972 Apr;29(4):1052-6 - PubMed
    1. Eur J Biochem. 1981 Mar 16;115(1):207-16 - PubMed
    1. Cancer Treat Rep. 1978 Mar;62(3):333-40 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):85-91 - PubMed

Publication types

MeSH terms

LinkOut - more resources